vs

Side-by-side financial comparison of John Marshall Bancorp, Inc. (JMSB) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $16.8M, roughly 1.0× John Marshall Bancorp, Inc.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 36.3%, a 30.9% gap on every dollar of revenue.

John Marshall Bancorp, Inc. is a U.S.-based bank holding company that operates through its wholly owned subsidiary John Marshall Bank. It provides a full suite of commercial and consumer banking products including deposit accounts, commercial loans, residential mortgages, and personal financial services, primarily serving retail customers and small-to-mid-sized businesses across the U.S. Mid-Atlantic region.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

JMSB vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.0× larger
SLGL
$17.3M
$16.8M
JMSB
Higher net margin
SLGL
SLGL
30.9% more per $
SLGL
67.3%
36.3%
JMSB

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
JMSB
JMSB
SLGL
SLGL
Revenue
$16.8M
$17.3M
Net Profit
$6.1M
$11.6M
Gross Margin
Operating Margin
65.1%
Net Margin
36.3%
67.3%
Revenue YoY
217.7%
Net Profit YoY
26.8%
487.6%
EPS (diluted)
$0.43
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JMSB
JMSB
SLGL
SLGL
Q1 26
$16.8M
Q4 25
$16.4M
Q3 25
$16.3M
Q2 25
$15.4M
$17.3M
Q1 25
$14.6M
Q4 24
$14.3M
Q3 24
$13.8M
Q2 24
$12.6M
$5.4M
Net Profit
JMSB
JMSB
SLGL
SLGL
Q1 26
$6.1M
Q4 25
$5.9M
Q3 25
$5.4M
Q2 25
$5.1M
$11.6M
Q1 25
$4.8M
Q4 24
$4.8M
Q3 24
$4.2M
Q2 24
$3.9M
$2.0M
Operating Margin
JMSB
JMSB
SLGL
SLGL
Q1 26
Q4 25
47.4%
Q3 25
42.2%
Q2 25
42.7%
65.1%
Q1 25
42.4%
Q4 24
42.5%
Q3 24
38.8%
Q2 24
39.7%
29.9%
Net Margin
JMSB
JMSB
SLGL
SLGL
Q1 26
36.3%
Q4 25
36.2%
Q3 25
33.2%
Q2 25
33.1%
67.3%
Q1 25
32.9%
Q4 24
33.3%
Q3 24
30.7%
Q2 24
30.9%
36.4%
EPS (diluted)
JMSB
JMSB
SLGL
SLGL
Q1 26
$0.43
Q4 25
$0.41
Q3 25
$0.38
Q2 25
$0.36
$4.17
Q1 25
$0.34
Q4 24
$0.33
Q3 24
$0.30
Q2 24
$0.27
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JMSB
JMSB
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$150.2M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$268.1M
$31.9M
Total Assets
$2.4B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JMSB
JMSB
SLGL
SLGL
Q1 26
$150.2M
Q4 25
$130.0M
Q3 25
$163.6M
Q2 25
$116.9M
$24.3M
Q1 25
$169.1M
Q4 24
$122.5M
Q3 24
$177.2M
Q2 24
$182.6M
$26.5M
Total Debt
JMSB
JMSB
SLGL
SLGL
Q1 26
Q4 25
$80.9M
Q3 25
$80.9M
Q2 25
$80.8M
Q1 25
$80.8M
Q4 24
$80.8M
Q3 24
$80.8M
Q2 24
$24.7M
Stockholders' Equity
JMSB
JMSB
SLGL
SLGL
Q1 26
$268.1M
Q4 25
$265.6M
Q3 25
$259.7M
Q2 25
$253.7M
$31.9M
Q1 25
$253.0M
Q4 24
$246.6M
Q3 24
$243.1M
Q2 24
$235.3M
$34.9M
Total Assets
JMSB
JMSB
SLGL
SLGL
Q1 26
$2.4B
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.3B
$39.3M
Q1 25
$2.3B
Q4 24
$2.2B
Q3 24
$2.3B
Q2 24
$2.3B
$42.0M
Debt / Equity
JMSB
JMSB
SLGL
SLGL
Q1 26
Q4 25
0.30×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.32×
Q4 24
0.33×
Q3 24
0.33×
Q2 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JMSB
JMSB

Net Interest Income$16.5M98%
Noninterest Income$284.0K2%

SLGL
SLGL

Segment breakdown not available.

Related Comparisons